n-acetylneuraminic acid has been researched along with mannitol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lagarde, M; Lecomte, M; Rellier, N; Ruggiero, D; Wiernsperger, N | 1 |
| Deng, Y; Ding, J; Liu, M; Song, Y; Tang, X; Zhao, B | 1 |
2 other study(ies) available for n-acetylneuraminic acid and mannitol
| Article | Year |
|---|---|
Advanced glycation end products induce specific glycoprotein alterations in retinal microvascular cells.
Topics: Animals; Cattle; Cells, Cultured; Diabetic Retinopathy; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Galactose; Glucose; Glycation End Products, Advanced; Glycoproteins; Glycosylation; Lectins; Mannitol; Microcirculation; N-Acetylneuraminic Acid; Oligosaccharides; Protein Processing, Post-Translational; Retinal Vessels | 1997 |
A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bortezomib; Cell Line, Tumor; Cell Membrane Permeability; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Leukemia; Male; Mannitol; Mice; Molecular Targeted Therapy; N-Acetylneuraminic Acid; Prodrugs; Selectins | 2019 |